Dr Phillips on the Investigation of Acalabrutinib/Benendamustine/Rituximab in MCL
June 7th 2023Tycel Phillips, MD, MPH, discusses the safety and efficacy of acalabrutinib plus bendamustine and rituximab from a phase 1 trial in patients with treatment-naive and relapsed/refractory mantle cell lymphoma.
Read More